Fig. 2.

Kaplan-Meier estimate of survival for all patients. Survival probability (all patients) is displayed graphically using Kaplan-Meier, including summaries of the number of events (marked as a black star) and censored observations (marked as black circles). The red line represents ilixadencel and sunitinib strata (high and intermediate risk), and the blue line represents sunitinib strata (high and intermediate risk). The patients at risk for each stratum are indicated below the figure. CR = complete response.